May 10th 2024
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
April 30th 2024
Your daily dose of the clinical news you may have missed.
April 22nd 2024
Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.
March 29th 2024
Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.
March 19th 2024
The novel 21-valent pneumococcal vaccine remains on track for the FDA PDUFA date of June 17, 2024; Merck adds this new data to the body of positive evidence.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 18, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 14, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 11, 2022
Non-COVID-19 Vaccines Could Help Reduce the Burden of Pandemic, Suggests New Research
New research suggests heterologous vaccine interventions with low efficacy can significantly reduce COVID-19 cases, hospitalizations, and deaths.
Shingles Vaccine Recap: A Shingrix Primer for Primary Care
Herpes zoster vaccination rates in the US have ticked up only minimally since FDA approval of Shingrix. Brush up on the basics of the vaccine and pass it on to your patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 10, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 7, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 5, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 4, 2022
J&J Booster Found 85% Effective Against Severe Disease During Peak Omicron Case Load
The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 20, 2021
The CDC Recommends Pfizer, Moderna COVID Vaccines over J&J
The CDC recommends against the J&J COVID-19 vaccine if Pfizer or Moderna mRNA shots are available while affirming that any COVID vaccine is better than none.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 16, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 15, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 14, 2021
Flu Called out by COVID as "Irrelevant," Flu Calls Press Conference, Issues Statement
COVID-19, in an attempt to bully Flu and potentially gain precious lung space in humans this year, provoked the veteran virus, labeling him as "irrelevant." Flu responds.
Flu Responds to COVID-19 Allegations: Press Conference Transcript
Influenza takes questions from key media outlets to rebut assertions by COVID-19 that Flu's heyday has come to an end. He replies to MSNBC, Fox News, CBS, & the Christian Science Monitor.
FDA Extends Pfizer-BioNTech COVID-19 Vaccine Booster EUA to Cover 16-17-year-olds
Referencing waning immunity of the 2-dose mRNA series and availability of the vaccine to youth in this age group for more than a year, FDA determined that benefits outweigh risks.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 9, 2021
Pfizer: Protection Against Omicron Variant ‘Improved’ After 3 Doses of COVID-19 Vaccine
New preliminary laboratory data showed 3 doses of the Pfizer-BioNTech COVID-19 vaccine neutralized the Omicron variant while 2 doses reduced neutralization titers.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 8, 2021
Flu Takes Backseat to COVID-19: Survey of US Adults
Getting sick with COVID-19 is more worrisome to US adults than contracting the flu, the NFID found. How will that impact uptake of the flu shot this season?
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 7, 2021
J&J COVID-19 Booster May Offer More Protection in Mix-and-Match Scenario
A J&J booster shot following a 2-dose regimen of the Pfizer vaccine produced a greater CD8+ T-cell response than a third Pfizer dose, according to preliminary data.
Early Increase in Positive Flu Tests Seen Among Young Adults
Pockets of positive tests for influenza A(H3N2), including on college campuses, may herald the opening of the 2021-2022 flu season.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 2, 2021
NIH Influenza and COVID-19 Guideline Topline: Testing, Treatment, and Vaccination
The influenza and SARS-CoV-2 viruses once again are in cocirculation. Following is a topline look at the NIH guideline on their simultaneous management.